S Sridhar appointed as President of Organisation of Pharmaceutical Producers of India
Mumbai: The Organisation of Pharmaceutical Producers of India (OPPI), which represents research-based pharmaceutical companies in the country, has elected S. Sridhar as its next President. The term is for a period of two years and is effective from February 15, 2021. He takes over from Sharad Tyagi, former Managing Director, Boehringer Ingelheim India Pvt. Ltd.
Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc's commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. Sridhar is a strong voice of healthcare transformation in the country and was the chair of FICCI's Pharma Committee till recently.
Speaking on the new role, Sridhar said, "I am honoured to take over the responsibility of leading this prestigious organization at this important juncture for healthcare in India. The COVID-19 pandemic has put a spotlight on the significance of innovation and partnerships to respond to the country's healthcare needs. Healthcare today occupies as a priority agenda for the Government. OPPI stands for research, innovation, access and collaboration to help address the most pressing healthcare needs of the country. I look forward to making a difference to patients, the industry and the country as OPPI works with the Government on policies that are pro-patient, encourage innovation and provide for a positive environment for the industry to grow. I thank members of OPPI Executive Committee for selecting me for this role."
Welcoming Sridhar as President, Tyagi said, "It is a pleasure to welcome Sridhar as the new President. I am confident that under his stellar leadership, OPPI will charter a new path in the emerging healthcare order of the country where research and innovation are taking deep roots as foundations of the economy. It has been an honour to lead OPPI in the year of pandemic when the significance of healthcare sector is reaffirmed, and that I could contribute to the industry and the country in some humble ways.
Sridhar is a Chartered Accountant and has led various finance roles before joining the Pfizer Ltd. 13 years ago. At Pfizer Ltd, he expanded from his role as Chief Financial Officer to Business Unit head, took over the responsibility as the Managing Director of India Commerical Business, a position he has been holding for the past five years.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.